Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma

Improved therapies for individuals with head and neck squamous cell carcinoma (HNSCC) may be developed by identification of appropriate biomarkers. The aim of this study was to evaluate the usefulness of serum midkine measurement as a biomarker for HNSCC. Pretreatment serum midkine concentrations we...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Med
Auteurs principaux: Yamashita, Taku, Shimada, Hideaki, Tanaka, Shingo, Araki, Koji, Tomifuji, Masayuki, Mizokami, Daisuke, Tanaka, Nobuaki, Kamide, Daisuke, Miyagawa, Yoshihiro, Suzuki, Hiroshi, Tanaka, Yuya, Shiotani, Akihiro
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Clinical Cancer Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4799940/
https://ncbi.nlm.nih.gov/pubmed/26798989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.600
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires